Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Immunotherapy

Below is an extended Immunotherapy research listing. Click here to return to the Immunotherapy main in depth entry.

Recent Publications on Immunotherapy:

The role of microglia in central nervous system immunity and glioma immunology.
The central nervous system (CNS) historically has been considered an...
Direct Link
21st November, 2009
Department of Neurological Surgery, University of California at San
Advances in Immunotherapy for Tuberculosis Treatment.
Immunotherapies have the potential to improve the outcome in all patients...
Direct Link
21st November, 2009
Aurum Institute for Health Research, Suite 300, Private Bag X 30500,
Design and delivery of a cryptic PrP(C) epitope for induction of PrP(Sc)-specific antibody responses.
Transmissible spongiform encephalopathies (TSEs) depend on misfolding of a...
Direct Link
21st November, 2009
Vaccine and Infectious Disease Organization, University of Saskatchewan,
XPC gene variants: a risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy.
PURPOSE: To investigate the association between two Xeroderma pigmentosum...
Direct Link
20th November, 2009
Department of Urology and Renal Transplantation, Sanjay Gandhi Post
Molecular Analysis of Tumor-Promoting CD8(+) T Cells in Two-Stage Cutaneous Chemical Carcinogenesis.
T-pro are tumor-infiltrating TCRalphabeta(+)CD8(+) cells of reduced...
Direct Link
20th November, 2009
Department of Dermatology and Skin Diseases Research Center, Yale
Structural correlates of antibodies associated with acute reversal of A-beta related behavioral deficits in a mouse model of Alzheimer's disease.
Immunotherapy targeting amyloid beta (Abeta) peptide in transgenic mouse...
Direct Link
20th November, 2009
Elan Pharmaceuticals, United States;
Application of Nanotechnologies for Improved Immune Response Against Infectious Diseases in the Developing World.
There is an urgent need for new strategies to combat infectious diseases...
Direct Link
20th November, 2009
Department of Biomedical Engineering, P.O. Box 208260, New Haven, CT
Use of systemic therapy and factors affecting survival for patients undergoing cytoreductive nephrectomy.
OBJECTIVE To present a multi-institutional experience evaluating the use...
Direct Link
20th November, 2009
Department of Urological Oncology, Fox chase Cancer Center, Philadelphia,
Plasticity of T-cell phenotype and function: the T helper type 17 example.
Mature T helper type 1 (Th1) and Th2 cells antagonize the development of...
Direct Link
20th November, 2009
Department of Pediatrics, Program in Immunology, Stanford University
Characterization of an human leucocyte antigen A2-restricted Epstein-Barr virus nuclear antigen-1-derived cytotoxic T-lymphocyte epitope.
The Epstein-Barr virus (EBV) nuclear antigen 1 (EBNA1) is regularly...
Direct Link
20th November, 2009
Department of Biochemistry and Molecular Biology, University of Ferrara,
Interference of CD40L-mediated Tumor Immunotherapy by Oncolytic VSV.
Oncolytic virotherapy can be achieved in two ways: (1) by exploiting an...
Direct Link
20th November, 2009
Mayo Clinic, Molecular Medicine, Rochester, Minnesota, United States;
Dendritic cell recovery post-lymphodepletion: a potential mechanism for anti-cancer adoptive T cell therapy and vaccination.
Adoptive transfer of autologous tumor-reactive T cells holds promise as a...
Direct Link
19th November, 2009
Surgery Department, Medical University of South Carolina, Charleston, SC,
TNF-alpha-treated DC exacerbates disease in a murine tumor metastasis model.
Due to the pivotal role that dendritic cells (DC) play in eliciting...
Direct Link
19th November, 2009
Department of Translational Science, H. Lee Moffitt Cancer Center and
[Allergen-specific Immunotherapy for children and adolescents - a review on available products in Austria.]
A pediatric consensus report on allergen-specific immunotherapy for...
Direct Link
19th November, 2009
Univ.-Klinik fur Kinder und Jugendheilkunde, Austria,
A safety-modified SV40 Tag developed for human cancer immunotherapy. 19th November, 2009
Department of Urology, School of Medicine, University of Michigan, Ann

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.